These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pathogenesis of Charcot-Marie-Tooth disease. Gait analysis and electrophysiologic, genetic, histopathologic, and enzyme studies in a kinship. Sabir M, Lyttle D. Clin Orthop Relat Res; 1984 Apr; (184):223-35. PubMed ID: 6705352 [Abstract] [Full Text] [Related]
6. Pathogenesis of pes cavus in Charcot-Marie-Tooth disease. Sabir M, Lyttle D. Clin Orthop Relat Res; 1983 May; (175):173-8. PubMed ID: 6839584 [Abstract] [Full Text] [Related]
7. Prevalence of symptomatic Charcot-Marie-Tooth disease in Iceland: a study of a well-defined population. Gudmundsson B, Olafsson E, Jakobsson F, Lúthvígsson P. Neuroepidemiology; 2010 May; 34(1):13-7. PubMed ID: 19893324 [Abstract] [Full Text] [Related]
8. Charcot-Marie-Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles. Gallardo E, García A, Combarros O, Berciano J. Brain; 2006 Feb; 129(Pt 2):426-37. PubMed ID: 16317020 [Abstract] [Full Text] [Related]
9. New insights into the pathophysiology of pes cavus in Charcot-Marie-Tooth disease type 1A duplication. Berciano J, Gallardo E, García A, Pelayo-Negro AL, Infante J, Combarros O. J Neurol; 2011 Sep; 258(9):1594-602. PubMed ID: 21590514 [Abstract] [Full Text] [Related]
10. Treatment of the cavus foot. Deformity in the pediatric patient with Charcot-Marie-Tooth. Olney B. Foot Ankle Clin; 2000 Jun; 5(2):305-15. PubMed ID: 11232232 [Abstract] [Full Text] [Related]
11. Charcot-Marie-tooth disease. Casasnovas C, Cano LM, Albertí A, Céspedes M, Rigo G. Foot Ankle Spec; 2008 Dec; 1(6):350-4. PubMed ID: 19825739 [Abstract] [Full Text] [Related]
12. [Charcot-Marie-Tooth syndrome. Clinico-genetic correlation in an affected family]. Auer-Grumbach M, Wagner K, Strasser-Fuchs S, Millner M, Fazekas F. Nervenarzt; 1996 Feb; 67(2):155-9. PubMed ID: 8851297 [Abstract] [Full Text] [Related]
13. Foot measures in patients with pes cavus with and without charcot-marie-tooth disease: A pilot study. Stino AM, Atway S, Anthony M, Kline D, Kissel JT. Muscle Nerve; 2019 Jan; 59(1):122-125. PubMed ID: 30039580 [Abstract] [Full Text] [Related]
14. Randomized trial of botulinum toxin to prevent pes cavus progression in pediatric Charcot-Marie-Tooth disease type 1A. Burns J, Scheinberg A, Ryan MM, Rose KJ, Ouvrier RA. Muscle Nerve; 2010 Aug; 42(2):262-7. PubMed ID: 20544937 [Abstract] [Full Text] [Related]
15. Assessment and management of pes cavus in Charcot-Marie-tooth disease. Alexander IJ, Johnson KA. Clin Orthop Relat Res; 1989 Sep; (246):273-81. PubMed ID: 2766615 [Abstract] [Full Text] [Related]
16. Quantification of muscle strength and imbalance in neurogenic pes cavus, compared to health controls, using hand-held dynamometry. Burns J, Redmond A, Ouvrier R, Crosbie J. Foot Ankle Int; 2005 Jul; 26(7):540-4. PubMed ID: 16045845 [Abstract] [Full Text] [Related]
17. Evolution of foot and ankle manifestations in children with CMT1A. Burns J, Ryan MM, Ouvrier RA. Muscle Nerve; 2009 Feb; 39(2):158-66. PubMed ID: 19145658 [Abstract] [Full Text] [Related]
18. A comprehensive evaluation of the variation in ankle function during gait in children and youth with Charcot-Marie-Tooth disease. Õunpuu S, Garibay E, Solomito M, Bell K, Pierz K, Thomson J, Acsadi G, DeLuca P. Gait Posture; 2013 Sep; 38(4):900-6. PubMed ID: 23702343 [Abstract] [Full Text] [Related]
19. Initial semeiology in children with Charcot-Marie-Tooth disease 1A duplication. Berciano J, García A, Combarros O. Muscle Nerve; 2003 Jan; 27(1):34-9. PubMed ID: 12508292 [Abstract] [Full Text] [Related]